The factors in favour of a rise in the Pfizer share price:
First of all, it is important to remember that the Pfizer Group is one of the giants of the pharmaceutical industry throughout the world. It has been able to achieve this very advantageous positioning thanks to a very strong international presence, as it operates in more than fifty different countries.
This brings us to another of the company's assets, which this time concerns the good geographical distribution of its sources of revenue. By marketing its products throughout the world, Pfizer ensures good protection against geo-economic risks over the long term.
Of course, another strength of the Pfizer Group is its capacity for innovation, which enables it to stand out effectively from the competition by developing products that are both innovative and respond to new consumer needs. To achieve this goal, Pfizer naturally invests a great deal of money in research and development and employs highly qualified researchers.
In addition, the economic and financial history of the company shows that the Pfizer Group has often been involved in mergers and acquisitions of major pharmaceutical brands around the world. This strategy has, of course, provided the company with a significant expansion and has contributed to strengthening its brand image.
The Pfizer brand is in itself an undeniable asset of the group since it is known worldwide and is associated with a rather positive image among patients, doctors and other pharmacists.
Finally, the Pfizer Group's large workforce of more than 100,000 employees throughout its organisation is of course also an advantage for the future of the group, which can thus respond effectively to demand and new market needs, both in terms of production and development.